IMFINZI Study in Patients With Extensive Stage Small Cell Lung Cancer

CompletedOBSERVATIONAL
Enrollment

248

Participants

Timeline

Start Date

April 22, 2021

Primary Completion Date

July 25, 2023

Study Completion Date

July 25, 2023

Conditions
Carcinoma, Small Cell
Trial Locations (18)

Unknown

Research Site, Chiba

Research Site, Fukuoka

Research Site, Gunma

Research Site, Hokkaido

Research Site, Hyōgo

Research Site, Kanagawa

Research Site, Miyagi

Research Site, Nagano

Research Site, Nagasaki

Research Site, Nara

Research Site, Numakunai

Research Site, Okayama

Research Site, Osaka

Research Site, Saitama

Research Site, Shizuoka

Research Site, Tokyo

Research Site, Tottori

Research Site, Wakayama

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY